Pharmacotherapeutic Management of Pediatric Lymphoma.

about

Pharmacotherapeutic Management of Pediatric Lymphoma.

Item

http://www.wikidata.org/entity/Q48321203

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacotherapeutic Management of Pediatric Lymphoma.

@en

Pharmacotherapeutic Management of Pediatric Lymphoma.

@nl

type

Item

label

Pharmacotherapeutic Management of Pediatric Lymphoma.

@en

Pharmacotherapeutic Management of Pediatric Lymphoma.

@nl

prefLabel

Pharmacotherapeutic Management of Pediatric Lymphoma.

@en

Pharmacotherapeutic Management of Pediatric Lymphoma.

@nl

P1476

Pharmacotherapeutic Management of Pediatric Lymphoma

@en

P2093

Ante Botzen

http://www.w3.org/2001/XMLSchema#string

Dieter Körholz

http://www.w3.org/2001/XMLSchema#string

Julia Baumann

http://www.w3.org/2001/XMLSchema#string

Katharina Körholz

http://www.w3.org/2001/XMLSchema#string

Natascha Ströter

http://www.w3.org/2001/XMLSchema#string

P2860

Cooperative epigenetic modulation by cancer amplicon genes

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

The blockade of immune checkpoints in cancer immunotherapy

PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.

Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group.

The genetic landscape of mutations in Burkitt lymphoma.

P2888

s40272-017-0265-x

P304

43-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-017-0265-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christine Mauz-Körholz

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29127674

http://www.w3.org/2001/XMLSchema#string